Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
about
Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activityAzathioprine (Imuran) administration and the development of malignant lymphomas in NZB miceEffects of azathioprine on the human mixed lymphocyte reaction (MLR).Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiolIn vitro oxidative metabolism of 6-mercaptopurine in human liver: insights into the role of the molybdoflavoenzymes aldehyde oxidase, xanthine oxidase, and xanthine dehydrogenaseImmunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes.6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1Inhibition of the development of tolerance to morphine in rats by drugs which inhibit ribonucleic acid or protein synthesis.Effect of 6-thioguanine on Chlamydia trachomatis growth in wild-type and hypoxanthine-guanine phosphoribosyltransferase-deficient cellsStudies on the anti-inflammatory action of 6-mercaptopurine.Mechanisms in the suppression of delayed hypersensitivity in the guinea pig by 6-mercaptopurineCombination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors.Cyclophosphamide and whole organ transplantation in human beings.Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4).Significance of azathioprine metabolites.Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases.Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA.Simultaneous Determination of 6-Mercaptopurine and its Oxidative Metabolites in Synthetic Solutions and Human Plasma using Spectrophotometric Multivariate Calibration Methods.Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.Purines as 'hyper-repressors' of glucose transport. A role for phosphoribosyl diphosphate.Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms.The effect of azathioprine (Imuran) on the cell cycle of promonocytes and the production of monocytes in the bone marrow.Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors.
P2860
Q24674721-160C2AA1-F910-47AA-A04F-FC921AD7D093Q28362991-2E4C1410-BCCA-4C10-9B86-AFB7EB82A67EQ28365974-DEB6BD98-A8EF-4A70-9553-EE3B5B19CC0AQ28486322-B432051E-EF51-45AD-9168-1D1C037B1B3BQ33285055-1C96D8B6-B03D-42EF-9207-FCF8B5715AFAQ33942988-E8152827-724C-4513-811A-0C92D76C4528Q34475371-E8BE3762-1A38-4AF6-92C2-6F55B6768A6FQ34519049-DE40D8CE-DE3F-46F5-99F5-D35D8963CA96Q34629933-A5362255-5F00-4250-918B-F89265A2BADBQ35225880-CC5BF0F1-0666-41B5-B75B-D99CB8136F26Q36111267-E6F8535F-3437-4643-B453-37D52635BE3EQ36269299-50B9D4A3-26B8-45DE-9331-863ED3F27D8AQ36272265-56E64505-2910-4C63-B575-A2AE060A83C1Q36302849-398D8022-1711-4AF1-BF42-7786895FB73CQ36535994-6A898BD3-EC83-4EB4-9FAD-272597E9FE38Q36876245-E556549F-CC06-4D81-A344-CC14E4EDD113Q37389143-E57BCDF0-05A7-4CDD-BDF3-342167CD9474Q37399109-C594967B-1EAA-4104-B8B9-D4BA3E3A9A66Q39369334-563CE5D1-ADB9-4CE9-AC3F-23010748DDC7Q39369399-B840BFA9-E093-47FA-9D36-5FCC0B9EDEB2Q40452331-FFDE8796-E2C3-40CE-8DCD-D5B26F991D4CQ40553553-C05822AF-68A2-4057-958B-D2D13E9AE42EQ41487228-ED199F2F-FCED-4266-8560-DA1AB3BAC74EQ41888003-B1B63EB9-5AE4-42A0-BBA5-1B367A85B044Q42532024-08659942-6FEE-45D7-B853-BEC714F1F715Q42940144-08D41CA1-9517-4602-92C5-B8989BD4CC87Q43116555-57BCDCA5-DBB5-47F6-B1EB-A9663E8B7628
P2860
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
1967年论文
@zh
1967年论文
@zh-cn
name
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
@en
type
label
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
@en
prefLabel
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
@en
P1433
P1476
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
@en
P2093
P304
P407
P577
1967-05-01T00:00:00Z